Adherence and Patients' Attitudes to Oral Anticancer Drugs: A Prospective Series of 201 Patients Focusing on Targeted Therapies

Publisher： Karger

E-ISSN： 1423-0232|88|1|1-8

ISSN： 0030-2414

Source： Oncology, Vol.88, Iss.1, 2014-09, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 5, 2015-05 ,pp. : 798-806

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticancer Drugs in End‐Stage Kidney Disease Patients

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 413-416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trends in RA patients’ adherence to subcutaneous anti-TNF therapies and costs

By Borah Bijan J.   Huang Xingyue   Zarotsky Victoria   Globe Denise  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1365-1377

Informa Healthcare

Access to resources Recommend Favorite

Plasma Diamine Oxidase Activity Is a Useful Biomarker for Evaluating Gastrointestinal Tract Toxicities during Chemotherapy with Oral Fluorouracil Anti-Cancer Drugs in Patients with Gastric Cancer

By  

Oncology, Vol. 82, Iss. 3, 2012-03 ,pp. : 147-152

Karger

Access to resources Recommend Favorite

Persistence and adherence to disease modifying drugs among patients with multiple sclerosis

By Reynolds Matthew W.   Stephen Reejis   Seaman Chris   Rajagopalan Kitty  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 663-674

Informa Healthcare

Access to resources Recommend Favorite